Journal
JOURNAL OF PURE AND APPLIED MICROBIOLOGY
Volume 14, Issue 1, Pages 25-29Publisher
DR M N KHAN
DOI: 10.22207/JPAM.14.1.05
Keywords
2019-nCoV; COVID-19; Respiratory disease; Safety measures; Viral vaccine; Surface proteins; Control precautions
Categories
Ask authors/readers for more resources
The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus (2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks. Among several epidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is an important measure to track record the overall proportion/ratio of the cumulative number of infected patients with the known outcome (confirmed, recovered, or deceased). Considering the ongoing fatality rate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viral vaccine development are discussed herein. The prompt identification of high-risk entities to confront the uncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement to tackle the current COVID-19 severity. Moreover, the protein visualization available at the viral surface/body can give further insight into the appropriate vaccine development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available